The Lancet Respiratory Medicine: Sleep apnea media alert
Sleep apnoea and the brain: a complex relationship - by Dr Ivana Rosenzweig et al
Obstructive sleep apnoea (OSA) is a common disease that has implications for both neurocognitive and cardiovascular health [1]. This Review, published in The Lancet Respiratory Medicine, discusses both the neural adaptive and maladaptive processes in response to low oxygen levels in the blood (hypoxaemia) which is common in patients with OSA, as well as OSA's effect on cognitive and emotional performance. The authors also explore the contribution to health of fragmented sleep, and the disruption of sleep structure, with a focus on the effect at different times in the development of disease.
INFORMATION:
NOTES TO EDITORS:
[1] Health implications for OSA sufferers can include intermittent hypoxia, reoxygenation, and hypercapnia or hypocapnia occur in both adults and children during untreated apnoea and hypopnoea, along with changes in cerebral blood flow and sleep fragmentation.
On the cutting edge of obstructive sleep apnoea: where next? - by Professor Atul Malhotra et al
Obstructive sleep apnoea (OSA) is an increasingly common disease whose major neurocognitive and cardiovascular outcomes are becoming better documented. At the same time, sleep medicine is changing rapidly, with emerging diagnostics and treatments that favour home-based rather than laboratory-based management approaches. This Rapid Review, published in The Lancet Respiratory Medicine, discusses the most recent insights and discoveries in obstructive sleep apnoea, with a focus on diagnostics and therapeutics. The authors go on to explore the possibility of a more personalised approach in treating OSA.